600488 津藥藥業
按盤價 
5.240 +0.480 (+10.084%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.287 | 4.440 | 3.950 | 1.187 | 1.626 |
| 總資產報酬率 ROA (%) | 1.216 | 2.254 | 1.830 | 0.545 | 0.777 |
| 投入資產回報率 ROIC (%) | 1.799 | 3.370 | 2.653 | 0.762 | 1.075 | 邊際利潤分析 |
| 銷售毛利率 (%) | 40.761 | 45.445 | 46.425 | 49.073 | 47.634 |
| 營業利潤率 (%) | 8.802 | 7.015 | 4.478 | 1.903 | 3.890 |
| 息稅前利潤/營業總收入 (%) | 6.127 | 7.292 | 4.902 | 1.132 | 5.183 |
| 淨利潤/營業總收入 (%) | 5.032 | 6.476 | 4.300 | 0.500 | 2.899 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 170.623 | 122.907 | 114.509 | 1,621.443 | 122.055 |
| 價值變動淨收益/利潤總額(%) | 0.678 | -4.014 | -0.669 | -179.255 | 3.344 |
| 營業外收支淨額/利潤總額(%) | -53.245 | 0.423 | -0.694 | -460.919 | 2.169 | 償債能力分析 |
| 流動比率 (X) | 1.736 | 1.485 | 1.086 | 1.035 | 0.930 |
| 速動比率 (X) | 1.194 | 0.949 | 0.713 | 0.528 | 0.448 |
| 資產負債率 (%) | 32.192 | 31.806 | 38.896 | 43.557 | 39.845 |
| 帶息債務/全部投入資本 (%) | 18.748 | 15.280 | 23.921 | 33.617 | 31.612 |
| 股東權益/帶息債務 (%) | 411.515 | 524.793 | 300.551 | 187.495 | 206.843 |
| 股東權益/負債合計 (%) | 163.513 | 168.688 | 123.622 | 102.611 | 118.388 |
| 利息保障倍數 (X) | 15.986 | 29.552 | 10.775 | 1.428 | 4.295 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 51.867 | 40.374 | 36.739 | 41.144 | 42.241 |
| 存貨周轉天數 (天) | 130.234 | 141.355 | 167.252 | 204.385 | 190.760 |
| 備註： | 即時報價更新時間為 31/03/2026 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
